Syntara Limited (ASX:SNT)

Australia · Delayed Price · Currency is AUD

0.0310

+0.0015 (5.08%)

Mar 25, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Medicines for Blood Cancers and Conditions Linked to Inflammation and Fibrosis	7.30M	5.76M	6.23M	5.68M	544.00K
Medicines for Blood Cancers and Conditions Linked to Inflammation and Fibrosis Growth	26.61%	-7.51%	9.70%	944.30%	-89.46%
Mannitol Respiratory Business	-	-	-	9.77M	22.67M
Mannitol Respiratory Business Growth	-	-	-	-56.90%	221.64%
Corporate	-	-	-	308.00K	416.00K
Corporate Growth	-	-	-	-25.96%	-9.37%
Total	7.30M	5.76M	6.23M	15.76M	23.63M
Total Growth	26.61%	-7.51%	-60.45%	-33.31%	86.55%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Australia	917.00K	1.41M
Australia Growth	-34.83%	-15.09%
Western Europe	790.00K	813.00K
Western Europe Growth	-2.83%	-69.18%
Europe	770.00K	564.00K
Europe Growth	36.52%	-38.16%
USA & Canada	334.00K	98.00K
USA & Canada Growth	240.82%	36.11%
South Korea	267.00K	350.00K
South Korea Growth	-23.71%	1.45%
Central and Eastern Europe	506.00K	636.00K
Central and Eastern Europe Growth	-20.44%	176.52%
Russia	2.23M	1.37M
Russia Growth	63.08%	16.37%
United States	1.62M	1.45M
United States Growth	11.68%	-
Total	7.43M	6.68M
Total Growth	11.17%	-4.94%

Source: S&P Global Market Intelligence.